The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interaction

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Newie, Inga ^a,d   Søkilde, Rolf ^a,d   Persson, Helena ^d   Grabau, Dorthe ^c   Rego, Natalia ^d,e   Kvist, Anders ^d   Von Stedingk, Kristoffer ^a,d   Axelson, Håkan ^a,d   Borg, Åke ^a,b,d   Vallon Christersson, Johan ^b,d   Rovira, Carlos ^a,b,d  

^a BioCare Strategic Cancer Research Program   (Sweden)

^b CREATE Health   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MICRORNA; MICRORNA 30A; MICRORNA 4728 3P; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA, HUMAN; NUCLEOTIDE; TUMOR MARKER;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; MOLECULAR INTERACTION; NUCLEOTIDE MOTIF; NUCLEOTIDE SEQUENCE; ONCOGENE NEU; PROTEIN EXPRESSION; PROTEIN INTERACTION; RNA BINDING; THERMOSTABILITY; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NUCLEOTIDES; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84901353391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097200     Document Type: Article

References (39)

1. Padhy LC, Shih C, Cowing D, Finkelstein R, Weinberg RA (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28: 8652871.
2. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, et al. (1984) The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312: 513-516. (Pubitemid 15182278)
3. Zaczek A, Brandt B, Bielawski KP (2005) The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. Histol Histopathol 20: 1005-1015. (Pubitemid 40932618)
4. Moasser MM (2007) The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 26: 6469-6487.
5. Olayioye MA (2001) Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res 3: 385-389. (Pubitemid 34196365)
6. Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE (2009) Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors. Breast Cancer Res 11: R11.
7. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, et al. (2011) Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res 71: 78-86.
8. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798. (Pubitemid 38058492)
9. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
10. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, et al. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906. (Pubitemid 30130993)
11. Ha I, Wightman B, Ruvkun G (1996) A bulged lin-4/lin-14 RNA duplex is sufficient for Caenorhabditis elegans lin-14 temporal gradient formation. Genes Dev 10: 3041-3050. (Pubitemid 26412530)
12. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105. (Pubitemid 46991392)
13. Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511. (Pubitemid 38372808)
14. Brennecke J, Stark A, Russell RB, Cohen SM (2005) Principles of microRNA-target recognition. PLoS Biol 3: e85.
15. Mortimer SA, Doudna JA (2013) Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure. Nucleic Acids Res 41: 4230-4240.
16. Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, et al. (2012) Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell 48: 760-770.
17. Khorshid M, Hausser J, Zavolan M, van Nimwegen E (2013) A biophysical miRNA-mRNA interaction model infers canonical and noncanonical targets. Nat Methods 10: 253-255.
18. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, et al. (2009) miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell 35: 610-625.
19. Chi SW, Hannon GJ, Darnell RB (2012) An alternative mode of microRNA target recognition. Nat Struct Mol Biol 19: 321-327.
20. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527. (Pubitemid 44854747)
21. Welinder C, Ekblad L (2011) Coomassie staining as loading control in Western blot analysis. J Proteome Res 10: 1416-1419.
22. van Dongen S, Abreu-Goodger C, Enright AJ (2008) Detecting microRNA binding and siRNA off-target effects from expression data. Nat Methods 5: 1023-1025.
23. Hofacker IL (2003) Vienna RNA secondary structure server. Nucleic Acids Res 31: 3429-3431.
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology 5: R80.
25. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773. (Pubitemid 40292988)
26. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, et al. (2010) Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 38: 789-802.
27. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153: 654-665.
28. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zollner H, Munding J, et al. (2012) MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33: 732-739.
29. Majoros WH, Ohler U (2007) Spatial preferences of microRNA targets in 3′ untranslated regions. BMC Genomics 8: 152.
30. Pinhel I, Hills M, Drury S, Salter J, Sumo G, et al. (2012) ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer. Breast Cancer Res 14: R46.
31. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, et al. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37: W273-276.
32. Chung YL, Sheu ML, Yang SC, Lin CH, Yen SH (2002) Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer. Int J Cancer 97: 306-312. (Pubitemid 34049020)
33. Lambert NJ, Gu SG, Zahler AM (2011) The conformation of microRNA seed regions in native microRNPs is prearranged for presentation to mRNA targets. Nucleic Acids Res 39: 4827-4835.
34. Schirle NT, MacRae IJ (2012) The crystal structure of human Argonaute2. Science 336: 1037-1040.
35. Burroughs AM, Ando Y, de Hoon MJ, Tomaru Y, Nishibu T, et al. (2010) A comprehensive survey of 3′ animal miRNA modification events and a possible role for 3′ adenylation in modulating miRNA targeting effectiveness. Genome Res 20: 1398-1410.
36. Borg A, Baldetorp B, Ferno M, Killander D, Olsson H, et al. (1994) ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer. Cancer Lett 81: 137-144. (Pubitemid 24184647)
37. Lipton A, Ali SM, Leitzel K, Demers L, Chinchilli V, et al. (2002) Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol 20: 1467-1472. (Pubitemid 34260524)
38. Guo S, Sonenshein GE (2004) Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol 24: 8681-8690. (Pubitemid 39245087)
39. Parra-Palau JL, Pedersen K, Peg V, Scaltriti M, Angelini PD, et al. (2010) A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers. Cancer Res 70: 8537-8546.